Clinical Trials on System; Lupus Erythematosus
Total 190411 results
-
Nektar TherapeuticsEli Lilly and CompanyCompletedSystemic Lupus ErythematosusUnited States
-
AmgenCompletedSystemic Lupus ErythematosusUnited States, Poland, Germany, France
-
Brigham and Women's HospitalPartners HealthCareActive, not recruitingSystemic Lupus ErythematosusUnited States
-
Eli Lilly and CompanyIncyte CorporationTerminatedSystemic Lupus ErythematosusUnited States, China, France, Czechia, Taiwan, Hungary, Belgium, Australia, Korea, Republic of, Serbia, Mexico, Poland, Italy, United Kingdom, Germany, Spain, Japan, South Africa, Austria, Russian Federation, Israel, India, Argentina, Croati... and more
-
DxTerity DiagnosticsActive, not recruitingSystemic Lupus ErythematosusUnited States
-
GlaxoSmithKlineActive, not recruitingSystemic Lupus ErythematosusUnited States, France, Italy, Spain, Israel, Germany, Belgium, Sweden, Canada, Slovakia, Austria, Portugal, Argentina
-
Cephalon, Inc.TerminatedSystemic Lupus ErythematosusUnited States, Belgium, Czechia, France, Germany, Hungary, Poland, Portugal, Spain, Ukraine, United Kingdom
-
Cugene Inc.Active, not recruitingSystemic Lupus ErythematosusUnited States
-
GlaxoSmithKlineHuman Genome Sciences Inc., a GSK CompanyActive, not recruitingSystemic Lupus ErythematosusPeru, United States, Spain, Argentina, United Kingdom, Poland, Canada, Russian Federation, Japan, Mexico
-
University Medical Center MainzJohannes Gutenberg University MainzCompleted
-
Loma Linda UniversityTerminated
-
Saiful Anwar HospitalCompletedSystemic Lupus ErythematosusIndonesia
-
Boston PharmaceuticalsCompletedSystemic Lupus ErythematosusUnited States, Philippines, Hungary, Poland, Mexico, Colombia, Ukraine, Peru, Romania, Argentina, Bulgaria, Georgia
-
Duke UniversityFood and Drug Administration (FDA)CompletedSystemic Lupus ErythematosusUnited States
-
AstraZenecaClinigen, Inc.No longer availableSystemic Lupus Erythematosus
-
Children's Hospital Medical Center, CincinnatiWatson PharmaceuticalsCompletedSystemic Lupus ErythematosusUnited States, Brazil
-
Genentech, Inc.Roche Pharma AGTerminatedSystemic Lupus Erythematosus
-
GlaxoSmithKlineCompletedSystemic Lupus ErythematosusChina
-
CelgeneCompletedSystemic Lupus ErythematosusUnited States
-
RemeGen Co., Ltd.CompletedSystemic Lupus ErythematosusChina
-
Assiut UniversityUnknownSystemic Lupus Erythematosus
-
Idorsia Pharmaceuticals Ltd.CompletedSystemic Lupus ErythematosusUnited States, Belarus, Bulgaria, Georgia, Russian Federation, Ukraine
-
Northwell HealthNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Terminated
-
BiotestCompletedSystemic Lupus ErythematosusBelarus, Georgia, Poland, Serbia
-
Xencor, Inc.PPD; ICON plcCompletedSystemic Lupus ErythematosusUnited States
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedSystemic Lupus ErythematosusUnited States, Canada
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedSystemic Lupus ErythematosusBrazil
-
ACEA Therapeutics, Inc.Hangzhou ACEA Pharmaceutical Research Co., Ltd.UnknownSystemic Lupus ErythematosusUnited States
-
Iltoo PharmaCompletedSystemic Lupus ErythematosusFrance, Spain, Mexico, Austria, Germany, Bulgaria, Italy, Mauritius, Portugal, Romania
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR)Completed
-
Wayne State UniversityMerck Sharp & Dohme LLCCompletedSystemic Lupus ErythematosusUnited States
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedSystemic Lupus ErythematosusUnited States
-
Medical University of South CarolinaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedSystemic Lupus ErythematosusUnited States
-
GlaxoSmithKlineCompleted
-
University of ChicagoMerck Sharp & Dohme LLCCompletedSystemic Lupus ErythematosusUnited States
-
23andMe, Inc.PfizerCompleted
-
Oklahoma Medical Research FoundationGlaxoSmithKlineUnknownSystemic Lupus ErythematosusUnited States
-
Vanderbilt UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
GlaxoSmithKlineTerminatedSystemic Lupus ErythematosusEstonia, Germany, South Africa, Peru, Sweden, France, Korea, Republic of, Hong Kong, Spain, Romania, Czechia, Argentina, Chile, Hungary, Greece, Poland
-
Human Genome Sciences Inc.GlaxoSmithKlineCompletedSystemic Lupus ErythematosusUnited States, Spain, Israel, Netherlands, Canada, Germany, Poland, Romania, Puerto Rico, Costa Rica, Belgium, Slovakia, United Kingdom, Mexico, Italy, Austria, Czech Republic, Sweden, France
-
Human Genome Sciences Inc.GlaxoSmithKlineCompletedSystemic Lupus ErythematosusHong Kong, Taiwan, Korea, Republic of, India, Chile, Argentina, Philippines, Colombia, Brazil, Romania, Australia, Peru, Russian Federation
-
University Hospital Center of MartiniqueCompleted
-
Assistance Publique - Hôpitaux de ParisCompletedSystemic Lupus ErythematosusFrance
-
UCB PharmaCompletedSystemic Lupus ErythematosusJapan
-
University of PittsburghNational Institutes of Health (NIH); Arthritis FoundationWithdrawnSystemic Lupus ErythematosusUnited States
-
Resolve TherapeuticsCompletedSystemic Lupus ErythematosusUnited States
-
Federal University of Minas GeraisCompletedSystemic Lupus Erythematosus
-
UCB Biopharma S.P.R.L.Pharmaceutical Research Associates; Richmond Pharmacology Limited; Eurofins; ACM... and other collaboratorsCompletedSystemic Lupus ErythematosusUnited Kingdom
-
AmgenCompleted
-
AmgenCompletedSystemic Lupus ErythematosusUnited States, United Kingdom